[Federal Register Volume 87, Number 176 (Tuesday, September 13, 2022)]
[Notices]
[Page 56078]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-19775]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Submission for OMB Review; 30-Day Comment Request: Request Human 
Embryonic Stem Cell Line To Be Approved for Use in NIH Funded Research 
(Office of the Director)

AGENCY: National Institutes of Health, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In compliance with the requirement of the Paperwork Reduction 
Act of 1995, the National Institutes of Health (NIH) Office of the 
Director has submitted to the Office of Management and Budget (OMB) a 
request for review and approval of the information listed below.

DATES: Comments regarding this information collection are best assured 
of having their full effect if received within 30 days of the date of 
this publication.

ADDRESSES: Written comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the data collection plans and 
instruments, contact: Dr. Ellen Gadbois, Office of the Director, NIH, 
building 1, Room 218, MSC 0166, 9000 Rockville Pike, Bethesda, Maryland 
20892, or call non-toll free number (301) 496-9838 or email your 
request, including your address to: [email protected].

SUPPLEMENTARY INFORMATION: This proposed information collection was 
previously published in the Federal Register on June 8, 2022, pages 
34892-34893 (87 FR 34892) and allowed 60 days for public comment. No 
public comments were received. The purpose of this notice is to allow 
an additional 30 days for public comment.
    The NIH Office of the Director may not conduct or sponsor, and the 
respondent is not required to respond to, an information collection 
that has been extended, revised, or implemented on or after October 1, 
1995, unless it displays a currently valid OMB control number.
    In compliance with section 3507(a)(1)(D) of the Paperwork Reduction 
Act of 1995, the National Institutes of Health (NIH) has submitted to 
the OMB a request for review and approval of the information collection 
listed below.
    Proposed Collection: Request for Human Embryonic Stem Cell Line to 
Be Approved for Use in NIH Funded Research. OMB No. 0925-0601 Extension 
--Expiration Date 10/31/2022--Office of the Director, NIH.
    Need and Use of Information Collection: This form is used by 
applicants to request that human embryonic stem cell lines be approved 
for use in NIH funded research. Applicants may submit applications at 
any time.
    OMB approval is requested for three years. There are no costs to 
respondents other than their time. The total estimated annualized 
burden hours are 255 per respondent.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of     Average time
               Type of respondent                    Number of     responses per   per response    Total annual
                                                    respondents     respondent      (in hours)      burden hour
----------------------------------------------------------------------------------------------------------------
NIH grantees and others with hESC lines.........               5               3              17             255
                                                 ---------------------------------------------------------------
    Total.......................................  ..............              15  ..............             255
----------------------------------------------------------------------------------------------------------------


    Dated: September 7, 2022.
Tara A. Schwetz,
Acting Principal Deputy Director, National Institutes of Health.
[FR Doc. 2022-19775 Filed 9-12-22; 8:45 am]
BILLING CODE 4140-01-P